-
3
pages
-
English
-
Documents
Description
Varying Technology and Application Trends Pep up the Mature Research Antibodies Market, Finds Frost & Sullivan PR Newswire MOUNTAIN VIEW, California, Aug. 30, 2012 - Pockets of growth and opportunities are available despite budgetary constraints that are likely for the next four years MOUNTAIN VIEW, California, Aug. 30, 2012 /PRNewswire/ -- A large competitor base and fluid market share has kept the research antibodies market highly competitive despite its maturity. Low entry barriers, large market size, and easy original equipment manufacturer (OEM) opportunities attract a wide variety of companies to this market. As research antibodies vary in quality by company, type, and even lot, customer satisfaction is hard to achieve. This translates to considerable chances for suppliers to capture market shares if they develop higher quality products. New analysis from Frost & Sullivan's (http://www.clinicaldiagnostics.frost.com) Strategic Analysis of the U.S. Research Antibodies Market research finds that the market earned revenues of $672.0 million in 2011 and estimates this to reach $775.0 million in 2016. This anticipated expansion is due to the high growth of various antibody-based technologies as well as the continued need for basic protein research. If you are interested in more information on this research, please send an email to Britni Myers, Corporate Communications, at britni.myers@frost.
-
Publié par
-
Langue
English